au.\*:("GOMMEREN W")
Results 1 to 16 of 16
Selection :
IN VITRO BINDING PROPERTIES OF 3H-SUFENTANIL, A SUPERIOR LIGAND FOR THE MU -OPIATE RECEPTORLEYSEN JE; GOMMEREN W.1982; ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE; ISSN 0003-9780; BEL; DA. 1982; VOL. 260; NO 2; PP. 287-289; BIBL. 2 REF.Article
DISCRIMINATION OF NARCOTIC DRUGS ON 3H-FENTANYL RECEPTOR BINDINGLEYSEN J; GOMMEREN W; LADURON P et al.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 220; NO 2; PP. 335-338; BIBL. 7 REF.Article
ENDOGENOUS LIGANDS FOR CNS DRUG RECEPTORS.LEYSEN JE; GOMMEREN W; LADURON PM et al.1978; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1978; VOL. 236; NO 2; PP. 310-314; BIBL. 14 REF.Article
IN VITRO AND IN VIVO BINDING CHARACTERISTICS OF A NEW LONG-ACTING HISTAMINE H1 ANTAGONIST, ASTEMIZOLELADURON PM; JANSSEN PFM; GOMMEREN W et al.1982; MOL. PHARMACOL.; ISSN 0026-895X; USA; DA. 1982; VOL. 21; NO 2; PP. 294-300; BIBL. 17 REF.Article
The dissociation rate of unlabelled dopamine antagonists and agonists from the dopamine-D2 receptor, application of an original filter methodLEYSEN, J. E; GOMMEREN, W.Journal of receptor research. 1984, Vol 4, Num 7, pp 817-845, issn 0197-5110Article
CHRONIC NEUROLEPTIC TREATMENT SPECIFICALLY ALTERS THE NUMBER OF DOPAMINE RECEPTORS IN RAT BRAINTHEODOROU A; GOMMEREN W; CLOW A et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 14; PP. 1621-1627; BIBL. 25 REF.Article
Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin releaseLEYSEN, J. E; GOMMEREN, W; JANSSEN, P. A. J et al.European journal of pharmacology. 1991, Vol 206, Num 1, pp 39-45, issn 0014-2999, 7 p.Article
Comparative study of central and peripheral histamine-H1 receptor binding in vitro and ex vivo of non-sedating antihistamines and of noberastine, a new agentLEYSEN, J. E; GOMMEREN, W; JANSSEN, P. F. M et al.Drug development research. 1991, Vol 22, Num 2, pp 165-178, issn 0272-4391, 14 p.Article
Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin ans setoperoneLEYSEN, J. E; VAN GOMPEL, P; GOMMEREN, W et al.Psychopharmacologia. 1986, Vol 88, Num 4, pp 434-444, issn 0033-3158Article
Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptorsCHIVERS, J. K; GOMMEREN, W; LEYSEN, J. E et al.Journal of pharmacy and pharmacology. 1988, Vol 40, Num 6, pp 415-421, issn 0022-3573Article
Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperoneLEYSEN, J. E; GOMMEREN, W; MERTENS, J et al.Psychopharmacologia. 1993, Vol 110, Num 1-2, pp 27-36, issn 0033-3158Article
Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugsLEYSEN, J. E; EENS, A; GOMMEREN, W et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 244, Num 1, pp 310-321, issn 0022-3565Article
Quantitative autoradiographic distribution of γ-hydroxybutyric acid binding sites in human and monkey brainCASTELLI, M. P; MOCCI, I; LANGLOIS, X et al.Molecular brain research. 2000, Vol 78, Num 1-2, pp 91-99, issn 0169-328XArticle
The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various β-adrenergic blockersPAUWELS, P. J; GOMMEREN, W; VAN LOMMEN, G et al.Molecular pharmacology. 1988, Vol 34, Num 6, pp 843-851, issn 0026-895XArticle
Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonistLEYSEN, J. E; GOMMEREN, W; VAN GOMPEL, P et al.Molecular pharmacology. 1985, Vol 27, Num 6, pp 600-611, issn 0026-895XArticle
